Jane Street
LAB icon

Jane Street’s Standard BioTools LAB Stock Holding History

Jane Street’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,800
Closed -$165K – 10360
2021
Q2 		$165K Sell
26,800
-34,100
-56% -$182K ﹤0.01% 8972
2021
Q1 		$275K Buy
60,900
+22,900
+60% +$126K ﹤0.01% 7820
2020
Q4 		$228K Sell
38,000
-52,300
-58% -$344K ﹤0.01% 6784
2020
Q3 		$671K Buy
+90,300
New +$623K ﹤0.01% 4721

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jane Street's LAB Position: Q1 2026 in Review

Jane Street sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 769,231 shares — an estimated $985K sold.

Jane Street first reported a position in LAB in Q1 2014 and held it in 26 quarters. The position peaked at $3.75M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Jane Street reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 769,231 Standard BioTools shares in Q1 2026, an estimated $985K.
  • Jane Street first reported a position in Standard BioTools in Q1 2014 and held it in 26 quarters.
  • Jane Street's Standard BioTools position peaked at $3.75M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.